Dataset from A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008553
下载链接
链接失效反馈官方服务：
资源简介：
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe
Atopic Dermatitis
创建时间：
2024-11-26
